
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Neuron navigator 2 CRISPR/Cas9 KO Plasmid (m) | sc-429641 | 20 µg | $397.00 |
Nav2 encodes neuron navigator 2, a neuron-enriched cytoskeletal-associated protein implicated in neurite extension, axon guidance, and neuronal migration through coordination of microtubule dynamics and growth cone behavior. In developing and mature mouse nervous system, NAV2 is linked to processes that shape neural circuit formation, including polarity establishment and directed outgrowth in response to guidance cues. Altered NAV2-associated pathways have been studied in the context of neurodevelopmental phenotypes and nervous system dysfunction where disrupted connectivity and axonal patterning are central features. As a result, Nav2 is a useful target for interrogating mechanisms of neuronal morphogenesis and cytoskeletal remodeling in disease-relevant cellular models.
Neuron navigator 2 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Nav2 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Nav2 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Nav2 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Neuron navigator 2 protein expression.
This CRISPR knockout system enables efficient generation of Nav2-deficient cell models for investigation of Neuron navigator 2 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.